By Business/Source
Currency:USD
2025/Q3
Stock NameRevenueRatio
Rare Disease and Brands129.13M56.68%
Generics and Other98.69M43.32%
By Country/Region
Currency:USD
2024/FY
Stock NameRevenueRatio
United States604.99M98.47%
International9.39M1.53%